The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digital calender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English
Deutsch
English
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets
NIL
Jahr
Publikationsjahr
2024
Autoren
Autorenliste der Publikation
Feige J, Moser T, Akgün K, Schwenker K, Hitzl W, Haschke-Becher E, Ziemssen T, Sellner J.
Verlag
Publisher-Information
Ann Clin Transl Neurol. 2024 Jan 10.
Link
Zur Publikation (externer Server)
https://doi.org/10.1002/acn3.51965
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
Neuroimmunologie
MSZ
Treatments
NIL
2024
MS360°: a conceptual digital-first, data-driven hybrid care framework for personalised multiple sclerosis management
MASC
Jahr
2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews
Multiple Sclerosis
Jahr
2026
Detecting progressing events in MS clinics in real-time is possible: No
Multiple Sclerosis
Jahr
2026
Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomes
MASC
Jahr
2025
Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis
NIL
Jahr
2025